Cosmeceuticals: No Rx Needed

There’s no doubt that the medispa is here to stay. There’s a steady market of clients that are looking for treatments best performed under a doctor’s watchful eye; but another market is emerging as well: those who want less invasive treatments with equally effective results. The global cosmeceuticals market is growing at a rate of 7.7% annually, and is poised to reach $42.4 billion by 2018. As the population ages and consumer awareness increases, so does the demand for these medically inspired skin care products.

“We observe a global trend in the cosmetic industry which shows that cosmetic companies are more and more following some processes inspired from the pharma companies,” notes Fabrice Lefevre, scientific marketing manager, Induchem. “As a consequence, molecules with a high level of purity, safety and efficiency become the holy grail of cosmetic companies.”

Brands featuring products with anti-aging ingredients such as peptides, stem cells and bioactives can likely expect to see strong sales—and brands that use effective marketing as well can expect to grow the most of all. The challenge for the product developer is balancing the demand for effective aging skin care with the demand for all-natural formulations.

Indeed, skin care offerings with medically oriented claims have to go one step further than most beauty products. They have to provide the outstanding, medispa-type results, and they must be able to be performed at home without a physician’s presence.


Lisa Doyle was formerly the associate editor of GCI magazine and is a freelance writer in the Chicago area. Her work has appeared in Skin Inc. magazine, Salon Today, America’s Best, Renew and Modern Salon.

More in Consumers/Market